JPH0249314B2 - - Google Patents
Info
- Publication number
- JPH0249314B2 JPH0249314B2 JP56099221A JP9922181A JPH0249314B2 JP H0249314 B2 JPH0249314 B2 JP H0249314B2 JP 56099221 A JP56099221 A JP 56099221A JP 9922181 A JP9922181 A JP 9922181A JP H0249314 B2 JPH0249314 B2 JP H0249314B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- ethylenediamine
- represented
- general formula
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000004033 porphyrin derivatives Chemical class 0.000 claims description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 14
- HUXSMOZWPXDRTN-UHFFFAOYSA-N methyl 16-ethenyl-11-ethyl-4-hydroxy-22-(3-methoxy-3-oxopropyl)-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaene-3-carboxylate Chemical compound CCC1=C(C2=NC1=CC3=C(C4=C(C(C(=C5C(C(C(=CC6=NC(=C2)C(=C6C)C=C)N5)C)CCC(=O)OC)C4=N3)C(=O)OC)O)C)C HUXSMOZWPXDRTN-UHFFFAOYSA-N 0.000 claims description 14
- HCFPRFJJTHMING-UHFFFAOYSA-N ethane-1,2-diamine;hydron;chloride Chemical compound [Cl-].NCC[NH3+] HCFPRFJJTHMING-UHFFFAOYSA-N 0.000 claims description 10
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- 125000003916 ethylene diamine group Chemical group 0.000 claims description 3
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 19
- 206010028980 Neoplasm Diseases 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 238000000862 absorption spectrum Methods 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 201000011510 cancer Diseases 0.000 description 7
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical class C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 7
- 150000004032 porphyrins Chemical class 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 229920005989 resin Polymers 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 241000192125 Firmicutes Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000005809 transesterification reaction Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- -1 phytyl ester Chemical class 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 239000001707 (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol Substances 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- MOTVYDVWODTRDF-UHFFFAOYSA-N 3-[7,12,17-tris(2-carboxyethyl)-3,8,13,18-tetrakis(carboxymethyl)-21,22-dihydroporphyrin-2-yl]propanoic acid Chemical compound N1C(C=C2C(=C(CC(O)=O)C(=CC=3C(=C(CC(O)=O)C(=C4)N=3)CCC(O)=O)N2)CCC(O)=O)=C(CC(O)=O)C(CCC(O)=O)=C1C=C1C(CC(O)=O)=C(CCC(=O)O)C4=N1 MOTVYDVWODTRDF-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 101100313763 Arabidopsis thaliana TIM22-2 gene Proteins 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- UJKPHYRXOLRVJJ-MLSVHJFASA-N CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C Chemical compound CC(O)C1=C(C)/C2=C/C3=N/C(=C\C4=C(CCC(O)=O)C(C)=C(N4)/C=C4\N=C(\C=C\1/N\2)C(C)=C4C(C)O)/C(CCC(O)=O)=C3C UJKPHYRXOLRVJJ-MLSVHJFASA-N 0.000 description 1
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- BLUHKGOSFDHHGX-UHFFFAOYSA-N Phytol Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C=CO BLUHKGOSFDHHGX-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- HNZBNQYXWOLKBA-UHFFFAOYSA-N Tetrahydrofarnesol Natural products CC(C)CCCC(C)CCCC(C)=CCO HNZBNQYXWOLKBA-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- BOTWFXYSPFMFNR-OALUTQOASA-N all-rac-phytol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)=CCO BOTWFXYSPFMFNR-OALUTQOASA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930002868 chlorophyll a Natural products 0.000 description 1
- 229930002869 chlorophyll b Natural products 0.000 description 1
- NSMUHPMZFPKNMZ-VBYMZDBQSA-M chlorophyll b Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C=O)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 NSMUHPMZFPKNMZ-VBYMZDBQSA-M 0.000 description 1
- 108010025790 chlorophyllase Proteins 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000000911 decarboxylating effect Effects 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229960003569 hematoporphyrin Drugs 0.000 description 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- GBCAVSYHPPARHX-UHFFFAOYSA-M n'-cyclohexyl-n-[2-(4-methylmorpholin-4-ium-4-yl)ethyl]methanediimine;4-methylbenzenesulfonate Chemical compound CC1=CC=C(S([O-])(=O)=O)C=C1.C1CCCCC1N=C=NCC[N+]1(C)CCOCC1 GBCAVSYHPPARHX-UHFFFAOYSA-M 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- CQIKWXUXPNUNDV-AXRVZGOCSA-N pheophytin a Chemical compound N1C(C=C2[C@H]([C@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=N2)C2=C3NC(=C4)C(C)=C3C(=O)[C@@H]2C(=O)OC)C)=C(C)C(C=C)=C1C=C1C(C)=C(CC)C4=N1 CQIKWXUXPNUNDV-AXRVZGOCSA-N 0.000 description 1
- ZQGOYEJYAYJFTL-BTMCAZCFSA-N pheophytin b Chemical compound N1C(C=C2[C@H]([C@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)C(=N2)C2=C3NC(=C4)C(C)=C3C(=O)[C@@H]2C(=O)OC)C)=C(C)C(C=C)=C1C=C1C(C=O)=C(CC)C4=N1 ZQGOYEJYAYJFTL-BTMCAZCFSA-N 0.000 description 1
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229950003776 protoporphyrin Drugs 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 150000003445 sucroses Chemical class 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明は新規な水溶性ポルフイリン誘導体に関
するものである。
一般にポルフイリン類(プロトポルフイリン、
ヘマトポルフイリン、ウロポルフイリンなど)を
担癌動物に静注すると、癌細胞はこの物質を正常
細胞の約2倍も多く取り込み、この癌細胞組織に
405nmの紫外線を照射すると、630および690nm
の赤色螢光を発するので、癌組織の検出判定に利
用されている。
また、ポルフイリン類は正常細胞よりも癌細胞
に対して親和性が強く、ポルフイリン類を取込ん
だ癌細胞に630nmの光照射を施すことによつて、
癌細胞は3日後に完全に死滅する。それ故、ポル
フイリン類は癌細胞の撲滅に有用な物質である。
しかしながら、かようなポルフイリン類は一般
に固体で脂溶性の物質であり、経口あるいは非経
口で動物に投与する場合には、水溶性物質に比べ
て動物の任意の部位への移動率は遅く、取り込ま
れる量も低レベルである。移動率を高めるため
に、エタノール、ジメチルスルホキシドなどの有
機溶媒でポルフイリン類を可溶化したり、CMC、
シヨ糖エステル、モノグリセリドなどの乳化剤を
使つて分散させることが行なわれているが、可溶
化、乳化、分散に際して特殊技術が必要となる。
そこで本発明者等は、ポルフイリン誘導体をそ
れ自体水溶化することを目的として鋭意研究を重
ねた結果、新規な水溶性ポルフイリン誘導体を得
ることに成功した。
すなわち本発明の水溶性ポルフイリン誘導体は
下記式()で表わされる構造を有するものであ
る。
(式中、R1はH2または
The present invention relates to novel water-soluble porphyrin derivatives. Generally, porphyrins (protoporphyrin,
When hematoporphyrin, uroporphyrin, etc.) are intravenously injected into tumor-bearing animals, cancer cells take up about twice as much of this substance as normal cells, and the cancerous tissue
When irradiated with 405nm ultraviolet light, 630 and 690nm
Because it emits red fluorescent light, it is used to detect and judge cancerous tissue. In addition, porphyrins have a stronger affinity for cancer cells than normal cells, and by irradiating cancer cells that have incorporated porphyrins with 630 nm light,
Cancer cells die completely after 3 days. Therefore, porphyrins are useful substances for eradicating cancer cells. However, such porphyrins are generally solid and fat-soluble substances, and when administered to animals orally or parenterally, their rate of movement to any part of the animal is slower than that of water-soluble substances, and their uptake is slow. The amount released is also at a low level. To increase the transfer rate, porphyrins are solubilized with organic solvents such as ethanol and dimethyl sulfoxide, and CMC,
Dispersion has been done using emulsifiers such as sucrose esters and monoglycerides, but special techniques are required for solubilization, emulsification, and dispersion. Therefore, the present inventors conducted extensive research aimed at making the porphyrin derivative itself water-soluble, and as a result, they succeeded in obtaining a new water-soluble porphyrin derivative. That is, the water-soluble porphyrin derivative of the present invention has a structure represented by the following formula (). (In the formula, R 1 is H 2 or
【式】 R2は−C2H5または[Formula] R 2 is −C 2 H 5 or
【式】 を表わし、R1が[Formula] represents, and R 1 is
【式】のときR2はWhen [formula], R 2 is
【式】である。ENはエチレンジ
アミン残基(−NH−CH2−CH2−NH2)を表わ
す。)
上記一般式()で表わされる水溶性ポルフイ
リン誘導体の具体例としては次のような化合物が
挙げられる。
(1) メチルピロフエオフオルバイドエチレンジア
ミン塩酸塩(以下MPPEHと略称する):
(2) メチルフエオフオルバイドエチレンジアミン
塩酸塩(以下MPEHと略称する):
(3) メチルメゾピロフエオフオルバイドエチレン
ジアミン塩酸塩(以下MMPPEHと略称す
る):
上記した本発明の水溶性ポルフイリン誘導体は
以下に示す方法で製造することができる。
まず、出発物質として下記一般式()で表わ
されるクロロフイル誘導体を使用する。
(式中、R3はH2または−COOCH3、R4は−CH
=CH2
または−C2H5を表わし、R3が−COOCH3のと
き
R4は−CH=CH2である。)
上記一般式()で表わされるクロロフイル誘
導体の具体例としては、次のような化合物が挙げ
られる。
(i) メチルピロフエオフオルバイド:
(ii) メチルフエオフオルバイド:
(iii) メチルメゾピロフエオフオルバイド:
上記のうちメチルフエオフオルバイドは、クロ
ロフイルからMgを解離し、7位の炭素における
フイチルエステルをメチルエステルに置換するこ
とにより容易かつ安価に得られる物質である。こ
のメチルフエオフオルバイドを製造する方法とし
ては、メタノールと塩酸あるいは硫酸のごとき鉱
酸を高濃度で混合した溶媒を用いて酸触媒エステ
ル交換を行なう方法や、クロロフイラーゼのよう
な酵素を触媒として含水メタノール中でエステル
交換を行なう方法などが採用できるが、本願発明
と同一出願人によつて既に特許出願された方法
(特開昭55−147286)によつて工業的に効率よく
製造することができる。この先願方法によれば、
クロロフイルaもしくはb、フエオフイチンaも
しくはb、またはこれらの誘導体の分子中にプロ
ピオニルエステルとして結合しているフイトール
を、多孔質強酸性イオン交換樹脂を触媒としてメ
タノールとの間でエステル交換することによつ
て、メチルフエオフオルバイドが製造される。
かくして得られるメチルフエオフオルバイドを
脱炭することによつてメチルピロフエオフオルバ
イドを製造することができ、またこのメチルピロ
フエオフオルバイドを水素添加することによつて
メチルピロフエオフオルバイドを製造することが
できる。これらのクロロフイル誘導体はいずれも
固体で脂溶性の物質である。
本発明方法によれば、上記一般式()で表わ
されるクロロフイル誘導体を無水条件下でエチレ
ンジアミンと反応させる。このとき得られる反応
生成物はいずれもそのままでは水溶性ではなく、
塩酸を添加して酸性となし塩酸塩とすることによ
つて初めて水溶性となる。この場合、硫酸、リン
酸などの無機酸や、シユウ酸、コハク酸、酒石酸
などの有機酸などを添加して酸性としても、安定
な水溶性化合物は得られない。
本発明方法における出発物質としてメチルピロ
フエオフオルバイドを用いることによつて
MPPEHが、メチルフエオフオルバイドを用いる
ことによつてMPEHが、メチルメゾピロフエオ
フオルバイドを用いることによつてMMPPEM
が、それぞれ本発明の水溶性ポルフイリン誘導体
として得られる。
かくして得られた水溶性ポルフイリン誘導体の
各種溶媒に対する溶解性を調べた結果を第1表に
示す。[Formula]. EN represents an ethylenediamine residue (-NH- CH2 - CH2 - NH2 ). ) Specific examples of the water-soluble porphyrin derivative represented by the above general formula () include the following compounds. (1) Methylpyropheophorbide ethylenediamine hydrochloride (hereinafter abbreviated as MPPEH): (2) Methylpheophorbide ethylenediamine hydrochloride (hereinafter abbreviated as MPEH): (3) Methyl mezopyropheophorbide ethylenediamine hydrochloride (hereinafter abbreviated as MMPPEH): The water-soluble porphyrin derivative of the present invention described above can be produced by the method shown below. First, a chlorophyll derivative represented by the following general formula () is used as a starting material. (In the formula, R 3 is H 2 or −COOCH 3 , R 4 is −CH
= CH2 or -C2H5 , and when R3 is -COOCH3 , R4 is -CH= CH2 . ) Specific examples of the chlorophyll derivative represented by the above general formula () include the following compounds. (i) Methylpyropheophorbide: (ii) Methylpheophorbide: (iii) Methyl mezopyropheophorbide: Among the above, methylpheophorbide is a substance that can be easily and inexpensively obtained by dissociating Mg from chlorophyll and replacing the phytyl ester at the 7-position carbon with a methyl ester. Methods for producing methylpheophorbide include acid-catalyzed transesterification using a solvent containing a highly concentrated mixture of methanol and a mineral acid such as hydrochloric acid or sulfuric acid, or acid-catalyzed transesterification using an enzyme such as chlorophyllase. Although a method such as transesterification in water-containing methanol can be adopted as the present invention, it cannot be produced industrially and efficiently by a method already filed for a patent by the same applicant as the present invention (Japanese Patent Laid-Open No. 147286/1986). Can be done. According to this first-to-file method,
By transesterifying phytol bound as a propionyl ester in the molecules of chlorophyll a or b, pheophytin a or b, or their derivatives with methanol using a porous strongly acidic ion exchange resin as a catalyst. , methylpheophorbide is produced. Methylpyropheophorbide can be produced by decarburizing the methylpyrofluoride obtained in this way, and methylpyrofluoride can be produced by hydrogenating the methylpyrofluoride. Bide can be produced. All of these chlorophyll derivatives are solid and fat-soluble substances. According to the method of the present invention, a chlorophyll derivative represented by the above general formula () is reacted with ethylenediamine under anhydrous conditions. None of the reaction products obtained at this time are water-soluble as they are;
It becomes water-soluble only when it is made acidic by adding hydrochloric acid to form a hydrochloride salt. In this case, even if an inorganic acid such as sulfuric acid or phosphoric acid or an organic acid such as oxalic acid, succinic acid or tartaric acid is added to make the solution acidic, a stable water-soluble compound cannot be obtained. By using methylpyropheophorbide as a starting material in the process of the invention
MPPEH by using methylpheophorbide and MMPPEM by using methyl mezopyropheophorbide.
are obtained as the water-soluble porphyrin derivatives of the present invention. Table 1 shows the results of examining the solubility of the thus obtained water-soluble porphyrin derivatives in various solvents.
【表】【table】
【表】
本発明による新規な水溶性ポルフイリン誘導体
は、前述したような一般のポルフイリン類と同様
に癌組織の検出判定、および紫外線照射による癌
細胞の撲滅に有用な化合物であり、従来のポルフ
イリン類が脂溶性であるのに対して水溶性である
ためその使用法も簡単で体内での移動率も良好に
なる。また、本発明のポルフイリン誘導体に導入
されたエチレンジアミン塩酸塩の反応性を利用し
て、各種の有用な化合物を得るための中間体とし
ての用途も期待できる。
さらにまた、本発明の水溶性ポルフイリン誘導
体はある種の微生物の発育を阻止する抗菌作用を
有していることが実験の結果判明した。抗菌性の
試験方法を下記に示す。
微生物培養地組成は次の通りである:
肉エキス 1%
ペプトン 1%
NaCl 0.5%
寒 天 1.5%
PH 7.0
上記培地をシヤーレにプレコートし、これに各
種微生物の試験管培養液をシヤーレの中心より放
射状に塗布した。本発明の水溶性ポルフイリン誘
導体のMPPEHとMPEHについては0.1M水溶液
を、またMMPPEHについては0.01M水溶液に
Tween80 0.5%添加した溶液をそれぞれ被検液と
し、この被検液を浸み込ませたロ紙デイスク
(9φ)を上記のシヤーレ中心部に置いて、30℃、
24hr、60w電球照射下で微生物を培養し、デイス
クによる微生物生育阻止力を調べた。結果を下表
に示す。[Table] The novel water-soluble porphyrin derivative according to the present invention is a compound useful for detecting cancer tissue and eradicating cancer cells by ultraviolet irradiation, similar to the general porphyrins mentioned above, Since it is water-soluble, whereas it is fat-soluble, it is easy to use and has a good rate of movement within the body. Further, by utilizing the reactivity of ethylenediamine hydrochloride introduced into the porphyrin derivative of the present invention, it can be expected to be used as an intermediate for obtaining various useful compounds. Furthermore, as a result of experiments, it has been found that the water-soluble porphyrin derivative of the present invention has an antibacterial effect that inhibits the growth of certain microorganisms. The antibacterial test method is shown below. The composition of the microbial culture medium is as follows: Meat extract 1% Peptone 1% NaCl 0.5% Agar 1.5% PH 7.0 The above medium was pre-coated on a shear dish, and test tube cultures of various microorganisms were spread radially from the center of the shear dish. It was applied to. The water-soluble porphyrin derivatives of the present invention, MPPEH and MPEH, were prepared in a 0.1M aqueous solution, and MMPPEH was added in a 0.01M aqueous solution.
A solution containing 0.5% Tween 80 was used as the test solution, and a paper disk (9φ) impregnated with this test solution was placed in the center of the shear plate, and heated at 30°C.
Microorganisms were cultured for 24 hours under 60W light bulb irradiation, and the ability of the disc to inhibit microbial growth was investigated. The results are shown in the table below.
【表】【table】
【表】
表からわかるように、本発明のポルフイリン誘
導体は、酵母、カビに対しては抗菌性を示さず、
細菌に対して選択的に抗菌性を示す。また細菌の
中でもグラム陰性菌とグラム陽性菌との間で抗菌
性に差が認められ、グラム陽性菌に対してより強
い抗菌性を有し、特にMMPPEHはグラム陰性菌
には抗菌性を示さず、グラム陽性菌にのみ作用す
るという特異性を有している。
以下本発明を実施例を挙げて具体的に説明する
が、本発明はその要旨を超えない限りこれら実施
例によつて限定されるものではない。
実施例 1
ジヤケツト付ガラス製カラムに多孔質強酸性イ
オン交換樹脂「レバチツトSP120」(バイエル社
製商品名)50mlを充填し、溶媒をアセトンに置換
しておく。これに原料として、スピルリナより得
られたクロロフイルペースト5gのアセトン溶液
を通液する。吸着、洗滌を十分に行なつた後、溶
媒をメタノールに置換し再び洗浄を溶出液が無色
になるまで行なう。次にジヤケツト内に60℃の温
水を通じて樹脂槽を保温し、そのままで数時間放
置する。反応終了後樹脂槽を室温まで冷却しメタ
ノール200mlを用いて洗浄を行なう。ここで溶離
溶媒として3%MgCl2−メタノール溶液をS.V.=
1〜2で300ml通液し、メチルフエオフオルバイ
ドを回収する。得られた溶出液に150ml加水し、
エーテル200mlを用いて液々分離することでメチ
ルフエオフオルバイドと無機物を分離し、エーテ
ル相を数回50mlの水で洗浄した後、蒸発乾固させ
る。次いで有機溶剤中で結晶化、カラム処理で精
製させることにより純度98.5%のメチルフエオフ
オルバイドを得た。
かくして得られたメチルフエオフオルバイド1
gにエチレンジアミン50gを加え、窒素気流中で
120℃に加熱還流し3時間反応させる。次いでエ
チレンジアミンを減圧蒸留で留去し、これに3%
塩酸水を添加してPH5.0に調整し可溶化して水溶
性MPEHの溶液を得る。このMPEH水溶液を多
孔性樹脂(三菱化成(株)製「HP20」)200mlを充填
したカラムに通し、未反応の塩酸とエチレンジア
ミンを水洗により除去し、MPEHはカラムに吸
着させる。メタノールまたはアセトンのいずれか
を溶離溶媒としてカラムに通液するとMPEHが
溶出する。溶出液中の溶離溶媒を減圧蒸留で除去
すると、約1gのMPEHが得られる。
この元素分析値は下記の通りである。
理論値 実測値
C 57.80% 56.95%
H 6.74 6.79
N 16.86 16.73
Cl 12.82 13.15
O 5.78 6.29
また、紫外−可視吸収スペクトルは第1図およ
び第2図に示す通りである。
実施例 2
メチルフエオフオルバイド(実施例1と同様に
調製、精製したもの)1gをピリジン中で脱炭酸
して得たメチルピロフエオフオルバイドに、エチ
レンジアミン50gを加え、窒素気流中で120℃に
加熱還流し3時間反応させる。以下、実施例1と
同様にしてエチレンジアミンの留去、塩酸添加に
よる塩酸塩の生成、および多孔性樹脂カラムによ
る精製を施して、約1gのMPPEHを得た。
この元素分析値は下記の通りである。
理論値 実測値
C 62.71% 60.34%
H 6.92 7.10
N 15.82 15.51
Cl 10.03 12.50
O 4.52 4.51
また、紫外−可視吸収スペクトルは第3図に示
す通りである。
実施例 3
メチルフエオフオルバイド(実施例2と同様に
調製、精製したもの)1gをピリジン中でPd−
C触媒存在下水素添加して得たメチルメゾピロフ
エオフオルバイドに、エチレンジアミン50gを加
え、窒素気流中で120℃に加熱還流し3時間反応
させる。以下、実施例と同様にしてエチレンジア
ミンの留去、塩酸添加による塩酸塩の生成、およ
び多孔性樹脂カラムによる精製を施して、約1g
のMMPPEHを得た。
この元素分析値は下記の通りである。
理論値 実測値
C 68.46% 67.24%
H 6.85 6.98
N 13.69 13.85
Cl 5.79 6.19
O 5.21 5.67
また、紫外−可視吸収スペクトルは第4図に示
す通りである。[Table] As can be seen from the table, the porphyrin derivative of the present invention does not exhibit antibacterial properties against yeast and mold.
Shows antibacterial properties selectively against bacteria. Furthermore, among bacteria, there is a difference in antibacterial properties between Gram-negative and Gram-positive bacteria, with stronger antibacterial properties against Gram-positive bacteria, and MMPPEH in particular does not show antibacterial properties against Gram-negative bacteria. , which has the specificity of acting only on Gram-positive bacteria. The present invention will be specifically described below with reference to Examples, but the present invention is not limited to these Examples unless the gist of the invention is exceeded. Example 1 A jacketed glass column was filled with 50 ml of a porous strongly acidic ion exchange resin "Revacht SP120" (trade name, manufactured by Bayer AG), and the solvent was replaced with acetone. A solution of 5 g of chlorophyll paste obtained from spirulina in acetone was passed through this as a raw material. After sufficient adsorption and washing, the solvent is replaced with methanol and washing is carried out again until the eluate becomes colorless. Next, heat the resin bath by running warm water at 60°C into the jacket and leave it as is for several hours. After the reaction is completed, the resin bath is cooled to room temperature and washed with 200 ml of methanol. Here, 3% MgCl 2 -methanol solution was used as the elution solvent SV=
1 to 2, 300 ml of liquid was passed through and methylpheophorbide was recovered. Add 150ml of water to the obtained eluate,
Methylpheophorbide and inorganic substances are separated by liquid-liquid separation using 200 ml of ether, and the ether phase is washed several times with 50 ml of water and then evaporated to dryness. Next, methylpheophorbide with a purity of 98.5% was obtained by crystallization in an organic solvent and purification by column treatment. The thus obtained methylpheophorbide 1
Add 50g of ethylenediamine to g and add it in a nitrogen stream.
Heat to reflux at 120°C and react for 3 hours. Next, ethylenediamine was distilled off under reduced pressure, and 3%
Add hydrochloric acid water to adjust the pH to 5.0 and solubilize to obtain a solution of water-soluble MPEH. This aqueous MPEH solution is passed through a column filled with 200 ml of porous resin (HP20 manufactured by Mitsubishi Kasei Corporation), unreacted hydrochloric acid and ethylenediamine are removed by washing with water, and MPEH is adsorbed onto the column. MPEH is eluted when either methanol or acetone is used as an eluent to pass through the column. When the eluent in the eluate is removed by vacuum distillation, about 1 g of MPEH is obtained. The elemental analysis values are as follows. Theoretical value Actual value C 57.80% 56.95% H 6.74 6.79 N 16.86 16.73 Cl 12.82 13.15 O 5.78 6.29 Moreover, the ultraviolet-visible absorption spectrum is as shown in FIGS. 1 and 2. Example 2 50 g of ethylenediamine was added to methylpyropheophorbide obtained by decarboxylating 1 g of methylpyropheophorbide (prepared and purified in the same manner as in Example 1) in pyridine, and the mixture was heated to 120 g in a nitrogen stream. The mixture was heated to reflux at ℃ and allowed to react for 3 hours. Thereafter, in the same manner as in Example 1, ethylenediamine was distilled off, hydrochloride was generated by adding hydrochloric acid, and purification was performed using a porous resin column to obtain about 1 g of MPPEH. The elemental analysis values are as follows. Theoretical value Actual value C 62.71% 60.34% H 6.92 7.10 N 15.82 15.51 Cl 10.03 12.50 O 4.52 4.51 Moreover, the ultraviolet-visible absorption spectrum is as shown in FIG. Example 3 1 g of methylpheophorbide (prepared and purified in the same manner as in Example 2) was dissolved in Pd-
50 g of ethylenediamine is added to methyl mezopyropheophorbide obtained by hydrogenation in the presence of catalyst C, and the mixture is heated to reflux at 120° C. in a nitrogen stream and reacted for 3 hours. Thereafter, in the same manner as in the example, ethylenediamine was distilled off, hydrochloride was generated by adding hydrochloric acid, and purified using a porous resin column, and approximately 1 g
Obtained MMPPEH. The elemental analysis values are as follows. Theoretical value Actual value C 68.46% 67.24% H 6.85 6.98 N 13.69 13.85 Cl 5.79 6.19 O 5.21 5.67 Moreover, the ultraviolet-visible absorption spectrum is as shown in FIG.
第1図はMPEHの水溶媒中での紫外−可視吸
収スペクトルを示し、第2図はMPEHのアルコ
ール溶媒中での紫外−可視吸収スペクトルを示
す。第3図はMPPEHのエタノール溶媒中での紫
外−可視吸収スペクトルを示す。第4図は
MMPPEHのエタノール溶媒中での紫外−可視吸
収スペクトルを示す。
FIG. 1 shows the ultraviolet-visible absorption spectrum of MPEH in an aqueous solvent, and FIG. 2 shows the ultraviolet-visible absorption spectrum of MPEH in an alcoholic solvent. Figure 3 shows the ultraviolet-visible absorption spectrum of MPPEH in ethanol solvent. Figure 4 is
The ultraviolet-visible absorption spectrum of MMPPEH in ethanol solvent is shown.
Claims (1)
す。) で表わされる水溶性ポルフイリン誘導体。 2 一般式()が下記式 で表わされるメチルピロフエオフオルバイドエチ
レンジアミン塩酸塩である特許請求の範囲第1項
記載の化合物。 3 一般式()が下記式 で表わされるメチルフエオフオルバイドエチレン
ジアミン塩酸塩である特許請求の範囲第1項記載
の化合物。 4 一般式()が下記式 で表わされるメチルメゾピロフエオフオルバイド
エチレンジアミン塩酸塩である特許請求の範囲第
1項記載の化合物。 5 一般式 (式中、R3はH2または−COOCH3、R4は−CH
=CH2または−C2H5を表わし、 R3が−COOCH3のときR4は−CH=CH2であ
る。) で表わされるクロロフイル誘導体をエチレンジア
ミンと反応させ、次いで塩酸と付加物を形成させ
ることを特徴とする 一般式 (式中、R1はH2または【式】 R2は−C2H5または【式】を表 わし、R1が【式】のときR2は 【式】である。ENはエチレンジ アミン残基(−NH−CH2−CH2−NH2)を表わ
す。) で表わされる水溶性ポルフイリン誘導体の製造方
法。 6 一般式()が下記式 で表わされるメチルピロフエオフオルバイドであ
り、一般式()が下記式 で表わされるメチルピロフエオフオルバイドエチ
レンジアミン塩酸塩である特許請求の範囲第5項
記載の製造方法。 7 一般式()が下記式 で表わされるメチルフエオフオルバイドであり、
一般式()が下記式 で表わされるメチルフエオフオルバイドエチレン
ジアミン塩酸塩である特許請求の範囲第5項記載
の製造方法。 8 一般式()が下記式 で表わされるメチルメゾピロフエオフオルバイド
であり、一般式()が下記式 で表わされるメチルメゾピロフエオフオルバイド
エチレンジアミン塩酸塩である特許請求の範囲第
5項記載の製造方法。[Claims] 1. General formula (In the formula, R 1 represents H 2 or [formula] R 2 represents -C 2 H 5 or [formula], and when R 1 is [formula], R 2 is [formula]. EN is an ethylenediamine residue A water-soluble porphyrin derivative represented by (-NH-CH 2 -CH 2 -NH 2 ). 2 General formula () is the following formula The compound according to claim 1, which is methylpyropheophorbide ethylenediamine hydrochloride represented by: 3 General formula () is the following formula The compound according to claim 1, which is methylpheophorbide ethylenediamine hydrochloride represented by: 4 General formula () is the following formula The compound according to claim 1, which is methyl mezopyropheophorbide ethylenediamine hydrochloride represented by: 5 General formula (In the formula, R 3 is H 2 or −COOCH 3 , R 4 is −CH
= CH2 or -C2H5 , and when R3 is -COOCH3 , R4 is -CH= CH2 . ) is reacted with ethylenediamine and then with hydrochloric acid to form an adduct. (In the formula, R 1 represents H 2 or [formula] R 2 represents -C 2 H 5 or [formula], and when R 1 is [formula], R 2 is [formula]. EN is an ethylenediamine residue (-NH- CH2 - CH2 - NH2 ).) A method for producing a water-soluble porphyrin derivative represented by: 6 The general formula () is the following formula It is methylpyropheophorbide represented by, and the general formula () is the following formula: The manufacturing method according to claim 5, which is methylpyropheophorbide ethylenediamine hydrochloride represented by: 7 General formula () is the following formula It is methylpheophorbide represented by
The general formula () is the following formula The manufacturing method according to claim 5, which is methylpheophorbide ethylenediamine hydrochloride represented by: 8 General formula () is the following formula It is methyl mezopyropheophorbide represented by, and the general formula () is the following formula: The manufacturing method according to claim 5, which is methyl mezopyropheophorbide ethylenediamine hydrochloride represented by.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56099221A JPS58981A (en) | 1981-06-26 | 1981-06-26 | Water-soluble porphyrin derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56099221A JPS58981A (en) | 1981-06-26 | 1981-06-26 | Water-soluble porphyrin derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS58981A JPS58981A (en) | 1983-01-06 |
JPH0249314B2 true JPH0249314B2 (en) | 1990-10-29 |
Family
ID=14241600
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56099221A Granted JPS58981A (en) | 1981-06-26 | 1981-06-26 | Water-soluble porphyrin derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS58981A (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4977177A (en) * | 1985-04-30 | 1990-12-11 | Nippon Petrochemicals Company, Ltd. | Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents |
CA1291710C (en) * | 1985-04-30 | 1991-11-05 | Jerry C. Bommer | Tetrapyrrole therapeutic agents |
JPS63122622A (en) * | 1986-11-10 | 1988-05-26 | Tama Seikagaku Kk | Agent for promoting 3rd component of complement |
US4744943A (en) * | 1986-12-08 | 1988-05-17 | The Dow Chemical Company | Process for the densification of material preforms |
JPH0786109B2 (en) * | 1987-12-21 | 1995-09-20 | 浜理薬品工業株式会社 | Pheophorbide derivative |
US5492924A (en) * | 1993-09-24 | 1996-02-20 | Fox Chase Cancer Center | Phorbine derivatives and their use in the diagnosis and therapy of cancer |
AU2816195A (en) * | 1994-06-02 | 1996-01-04 | Bar-Ilan University | Synergistic antibiotic compositions containing a perphyrin and an antibiotic |
WO2002013820A1 (en) * | 2000-08-11 | 2002-02-21 | Ceramoptec Industries, Inc. | Photosensitizing ointment |
JP5993077B1 (en) | 2015-10-19 | 2016-09-14 | 加賀ワークス株式会社 | Viscous material dispenser cartridge |
-
1981
- 1981-06-26 JP JP56099221A patent/JPS58981A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS58981A (en) | 1983-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Casiraghi et al. | Total synthesis of 6-deoxy-6-aminoheptopyranuronic acid derivatives | |
HU221102B1 (en) | Beta,beta'-dihydroxy meso-substituted chlorins, bacteriochlorins, isobacteriochlorins, and process for preparing thereof | |
AU777761B2 (en) | Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them | |
HU223379B1 (en) | Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof | |
JPH0249314B2 (en) | ||
EP0149995B1 (en) | Deuteroporphyrin derivative or salt thereof | |
Gensler et al. | Synthesis of a triazole homo-C-nucleoside | |
Nair et al. | Ring-extended products from the reaction of epoxy carbonyl compounds and nucleic acid bases | |
JPH0331260A (en) | Fucositase interruptor | |
Yang et al. | Neihumicin, a new cytotoxic antibiotic from Micromonospora neihuensis II. Structural determination and total synthesis | |
CN113999164B (en) | Preparation method of halofuginone intermediate trans-N-benzyloxycarbonyl- (3-hydroxy-2-piperidinyl) -2-propanone | |
US4965064A (en) | Pheophorbide derivatives | |
US4895854A (en) | Antitumor alkaloids | |
Kozyrev et al. | Syntheses and unusual spectroscopic properties of novel ketobacteriopurpurins | |
US4895852A (en) | Antitumor alkaloids | |
Suzuki et al. | Highly Stereoselective Synthesis of α-D-Glucopyranosides by the N-Iodosuccinimide-promoted Internal Cyclization | |
CA1321389C (en) | Antitumor alkaloids | |
US4290972A (en) | Process for the production of 4-aminobutyric acid or its derivatives | |
US5952376A (en) | Trienyl compounds | |
JPS6361959B2 (en) | ||
KR840001658B1 (en) | Process for the preparation of mycoplanecin derivatives | |
JP2006282577A (en) | Novel photosensitizer for photodynamic therapy of cancer | |
EP0209511A1 (en) | Hydrochlorides of 2-aminoalkyl-9-hydroxyellipticinium chloride derivatives, and pharmaceutical compositions containing them | |
CN106957319B (en) | Dihydroporphyrin derivative, preparation method and application | |
US4845246A (en) | Ascorbic acid ester |